Lysine Lactylation by AARS1 Inhibits p53 Tumor Suppressor Function

Skip Nav Destination

May 20, 2024

Major Finding: AARS1 mediates protein lactylation that couples cell metabolism and p53 tumor suppressor function.

Concept: AARS1 lactylates p53 at lysines 120 and 139 to block DNA binding and transcriptional activation.

Impact: Inhibiting p53 lactylation via β-alanine treatment may benefit patients with p53 wild-type cancers.

DOI:https://doi.org/10.1158/2159-8290.CD-RW2024-072

Article Type: Research Watch

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Lysine Lactylation by AARS1 Inhibits p53 Tumor Suppressor Function Available to Purchase